Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP802222.RAfWJqc8cUKKYsnmu-Cw6dpFCWLu4eiicWNhBPC8DkwoA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP802222.RAfWJqc8cUKKYsnmu-Cw6dpFCWLu4eiicWNhBPC8DkwoA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP802222.RAfWJqc8cUKKYsnmu-Cw6dpFCWLu4eiicWNhBPC8DkwoA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP802222.RAfWJqc8cUKKYsnmu-Cw6dpFCWLu4eiicWNhBPC8DkwoA130_provenance.
- NP802222.RAfWJqc8cUKKYsnmu-Cw6dpFCWLu4eiicWNhBPC8DkwoA130_assertion description "[Acquired mutations in the hematopoietic transcription factor GATA binding protein-1 (GATA1) are found in megakaryoblasts from nearly all individuals with Down syndrome with transient myeloproliferative disorder (TMD, also called transient leukemia) and the related acute megakaryoblastic leukemia (DS-AMKL, also called DS-AML M7).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802222.RAfWJqc8cUKKYsnmu-Cw6dpFCWLu4eiicWNhBPC8DkwoA130_provenance.
- NP802222.RAfWJqc8cUKKYsnmu-Cw6dpFCWLu4eiicWNhBPC8DkwoA130_assertion evidence source_evidence_literature NP802222.RAfWJqc8cUKKYsnmu-Cw6dpFCWLu4eiicWNhBPC8DkwoA130_provenance.
- NP802222.RAfWJqc8cUKKYsnmu-Cw6dpFCWLu4eiicWNhBPC8DkwoA130_assertion SIO_000772 15895080 NP802222.RAfWJqc8cUKKYsnmu-Cw6dpFCWLu4eiicWNhBPC8DkwoA130_provenance.
- NP802222.RAfWJqc8cUKKYsnmu-Cw6dpFCWLu4eiicWNhBPC8DkwoA130_assertion wasDerivedFrom befree-20140225 NP802222.RAfWJqc8cUKKYsnmu-Cw6dpFCWLu4eiicWNhBPC8DkwoA130_provenance.
- NP802222.RAfWJqc8cUKKYsnmu-Cw6dpFCWLu4eiicWNhBPC8DkwoA130_assertion wasGeneratedBy ECO_0000203 NP802222.RAfWJqc8cUKKYsnmu-Cw6dpFCWLu4eiicWNhBPC8DkwoA130_provenance.
- befree-20140225 importedOn "2014-02-25" NP802222.RAfWJqc8cUKKYsnmu-Cw6dpFCWLu4eiicWNhBPC8DkwoA130_provenance.